NEW YORK (GenomeWeb News) — When the National Human Genome Research Institute announced its grant awards this fall for 11 research groups working on innovative sequencing technologies, one big name stuck out: General Electric.
 
The company, whose GE Healthcare division has been selling Amersham Biosciences’ MegaBace sequencing technology since GE acquired Amersham in early 2004, has until now remained quiet about whether it is pursuing next-generation sequencing.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.